Tag: lung cancer

Biomarkers for Early Detection of Lung Cancer

Lung Cancer is individual of the leading causes for malignancy related deaths accompanying a 5-year endurance rate of only 18%.These are broadly divided into 2 types: NSCLC (non-limited cell alveolus cancer) and SCLC (small container lung tumor) and although treatments like a destructive agent, targeted situations are commonly used,...
Read More

How to Prepare Optimum Cell Blocks in Lung Cancer: A Clinical Approach

In high-risk patients, fine needle aspiration with cell blocks can be used to diagnose lung cancer. Because ancillary studies are critical for lung cancer diagnosis, subtyping, and prediction of targeted therapy response, good cellularity and morphology are critical. Due to a lack of consistency in cell block preparation processes,...
Read More

Comparative Study: Local Consolidation Therapy versus Observation for Oligometastatic Non Small Cell Lung Cancer Patients: Phase II Randomized Trial

We conducted phase II randomized study to determine whether oligometastatic NSCLC without disease progression after first line chemotherapy, have pro-longed progression free survival when treated with local consolidation therapy of residual disease followed by surveillance compared with no local consolidation therapy (observation). Forty eight eligible patients were randomized to...
Read More

Effect of Inhaled Tiotropium as the Perioperative Management of Patients Undergoing Pulmonary Resection for Primary Lung Cancer: Critical Study

Background: The purpose of this study was to evaluate the effectiveness of perioperative tiotropium therapy for patients undergoing pulmonary resection for primary lung cancer. The short-term tiotropium effect was investigated by perioperative pulmonary function and “lung age”.  Methods: The fifty-five patients who underwent a lobectomy and had tiotropium treatment...
Read More